BIOMAT Database Logo BIOMAT Database Logo

Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. 2002

Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Department of Surgery I, Oita Medical University, Oita, Japan. kyasuda@oita-med.ac.jp

BACKGROUND There is no consensus as to the impact of lymph node micrometastasis on survival of patients with gastric cancer. The aim of this study was to clarify the prognostic significance of lymph node micrometastasis in patients with histologically node-negative gastric cancer. METHODS Lymph nodes (n = 2039) from 64 patients with histologically node-negative gastric cancer (T2, T3) were evaluated for micrometastasis. Three serial 5- micro m sections of the resected lymph nodes were prepared for immunohistochemical staining with the anti-cytokeratin antibody CAM 5.2. RESULTS Micrometastasis was found in 73 of 2039 nodes (4%) and 20 of 64 patients (32%). The 5-year survival rate was significantly lower for patients with lymph node micrometastasis than for those without lymph node micrometastasis (66% vs. 95%, P <.01). The 5-year survival rate was significantly lower when there were four or more positive micrometastatic nodes (94% vs. 29%, P <.01) and when there were extragastric micrometastatic nodes (89% vs. 53%, P <.01). CONCLUSIONS Lymph node micrometastasis was associated with poor outcome in patients with histologically node-negative gastric cancer. The number and the level of lymph node micrometastases are useful prognostic markers for deciding treatment strategies for additional therapy and follow-up.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Prognostic impact of lymph node micrometastasis in patients with gastric cancer.
January 2022, Surgery today,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
April 2013, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Lymph node micrometastasis in node negative early gastric cancer.
April 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer.
July 2010, Annals of surgery,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
April 2002, Journal of surgical oncology,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Para-aortic lymph node micrometastasis in patients with node-negative biliary cancer.
January 2011, Digestive surgery,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Gene diagnosis and prognostic significance of lymph node micrometastasis after complete resection of histologically node-negative non-small cell lung cancer.
August 2008, World journal of surgery,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma.
June 2002, Cancer,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
March 2015, Annals of surgical oncology,
Kazuhiro Yasuda, and Yosuke Adachi, and Norio Shiraishi, and Masafumi Inomata, and Hiroaki Takeuchi, and Seigo Kitano
Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
March 2007, Hepato-gastroenterology,
Copied contents to your clipboard!